Previous research on the association between proton pump inhibitors (PPIs) intake and the increased risk of dementia has shown discrepancies in conclusion. We aimed to provide updated evidence based on extensive bias assessments and quantitative sensitivity analyses. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.